Abstract
Deficiency of the inhibitory FcγRIIB renders mice susceptible to autoimmune disorders characterized with cellular infiltration of target tissue. To analyze the role of FcγRIIB in an antibody-mediated autoimmune disease, experimental autoimmune myasthenia gravis (EAMG), FcγRIIB knockout (KO) and wild-type mice were immunized with acetylcholine receptor (AChR). In contrast with previous reports, FcγRIIB KO mice were mildly resistant to EAMG despite preserved anti-AChR antibody production and neuromuscular junction complement deposition capacity. EAMG resistance was associated with reduced lymph node cell IL-6 and IL-10 production and increased CD4+CD25+ cell ratios in lymph nodes. Our data suggest that FcγRIIB promotes antibody-mediated autoimmunity.
Original language | English (US) |
---|---|
Pages (from-to) | 44-53 |
Number of pages | 10 |
Journal | Journal of Neuroimmunology |
Volume | 194 |
Issue number | 1-2 |
DOIs | |
State | Published - Feb 2008 |
Externally published | Yes |
Keywords
- Autoimmunity
- FcγRIIB
- IL-10
- IL-6
- Myasthenia gravis
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Neurology
- Clinical Neurology